14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
TRMK vs BMA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Trustmark Corp (TRMK) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TRMK carries a Unified Composite Score of 48.3/100 (HOLD) at $47.63 (11.2x Forward P/E, 35.1% operating margin), whereas BMA carries 39.3/100 (SELL) at $53.85 (3.1x Forward P/E, 18.0% operating margin).
Technical & Structure Timing Caution: TRMK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.6); meanwhile BMA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TRMK vs BMA. Trailing 12-month operating profitability (TRMK 35.1% vs BMA 18.0%) and valuation multiples (TRMK 11.2x vs BMA 3.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Banks - Regional value chain with $2.8B market capitalization and 35.1% operating margin.
OpEx & R&D Reinvestment64.9% of Rev ($532M)
90D Engineering Disclosures0 Published
BMA Moat ProfileScale & Operating Efficiency Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $3.6B market capitalization and 18.0% operating margin.
OpEx & R&D Reinvestment80.7% of Rev ($2.81B)
90D Engineering Disclosures0 Published
Investor FAQ TRMK vs BMA Key Questions & Quantitative Answers
As of Nov 16, 2026, Trustmark Corp (TRMK) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TRMK carries a Unified Composite Score of 48.3/100 (HOLD) at $47.63 (11.2x Forward P/E, 35.1% operating margin), whereas BMA carries 39.3/100 (SELL) at $53.85 (3.1x Forward P/E, 18.0% operating margin). Technical & Structure Timing Caution: TRMK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.6); meanwhile BMA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
TRMK leads the Growth & Scale pillar: TRMK posts +2.1% YoY revenue growth and +6.4% YoY earnings growth on $819M TTM revenue (100.0% gross margin, 35.1% operating margin), compared with BMA at +1.2% YoY revenue growth and +3.5% YoY earnings growth on $3.48B TTM revenue (98.7% gross margin, 18.0% operating margin). On trailing 12-month operating scale, TRMK generates $819M in USD-normalized revenue versus $3.48B for BMA. In operating R&D and SG&A reinvestment, TRMK deploys 64.9% of Rev ($532M) (0 90-day corporate R&D disclosures) versus 80.7% of Rev ($2.81B) (0 disclosures) for BMA.
BMA screens cheaper on headline valuation multiples. TRMK trades at 11.2x Forward P/E, 12.0x Trailing P/E, 2.29x PEG, and 3.4x EV/Revenue (unreported cash flow margin), whereas BMA trades at 3.1x Forward P/E, 11.4x Trailing P/E, 0.47x PEG, and 1.0x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TRMK (11.2% ROE) versus BMA (7.1% ROE) capital efficiency.
In options market volatility and institutional positioning, TRMK carries 174.6% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.29β · 27% Vol realized risk). By comparison, BMA carries 77.3% implied volatility (51st %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.42β · 42% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.